What we are studying
The treatment of HIV infection requires the combination of several medications in order to decrease the amount of virus in the body, improve immune function and delay the progression of the disease. This has generally required patients to take a large number of pills each day, and many experience a loss of effectiveness of their current medication regimen over time or unacceptable side effects. Therefore, it is important to develop new drug regimens. In addition, the combination of drugs into a single tablet reduces the number of pills a patient has to take and makes it more convenient to stick to the prescribed drug regimen.
The purpose of this study is to evaluate safety and to determine whether a new combination drug is effective against HIV-1 in subjects on current antiretroviral regimens in virologically suppressed, HIV-1 positive subjects.